Literature DB >> 2022515

Prediction of severe late complications in fractionated, high dose-rate brachytherapy in gynecological applications.

M Van Lancker1, G Storme.   

Abstract

The pertinence of different points and volumes, proposed for reporting and prediction of complications in classical low dose-rate brachytherapy, was tested for high dose-rate, fractionated gynecological applications. A group of patients experiencing complications (especially rectal) was compared with a group treated without complications. We found that neither single reference points nor combinations of them are good predictors of late complications (p greater than 0.5). The same applies for the dose prescribed in point A. In contrast, volume calculations proved to be highly reliable, both in single applications as well as in cumulative calculations. It is concluded that, within the given treatment schedule, volumes up to 300 cm3 (as defined by ICRU report 38) can be treated safely.

Entities:  

Mesh:

Year:  1991        PMID: 2022515     DOI: 10.1016/0360-3016(91)90214-o

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  [Dosimetry methods in determining radiation dosage of the rectum in HDR-brachytherapy of cervix carcinoma].

Authors:  H T Eich; U Haverkamp; O Micke; F J Prott; R Pötter
Journal:  Strahlenther Onkol       Date:  1998-07       Impact factor: 3.621

2.  Radiochromic film dosimetry of rectal inhomogeneity and applicator attenuation in high dose rate brachytherapy of uterine cervix.

Authors:  Satish C Uniyal; Umesh C Naithani; Sunil D Sharma; Anoop K Srivastava
Journal:  J Appl Clin Med Phys       Date:  2012-01-05       Impact factor: 2.102

3.  Rectal dosimetry in intracavitary brachytherapy by HDR at rural center of Maharashtra: Comparison of two methods.

Authors:  Rajeev Shrivastava; Rahul B Umbarkar; M B Sarje; K K Singh
Journal:  J Med Phys       Date:  2009-04

4.  A prospective randomized study on two dose fractionation regimens of high-dose-rate brachytherapy for carcinoma of the uterine cervix: comparison of efficacies and toxicities between two regimens.

Authors:  Taek Keun Nam; Sung Ja Ahn
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.